Clinical Trial Update: OCS-05 in Patients With Optic Neuritis [Phase 2]

View source ↗

Summary

OCS-05 Phase 2 trial in optic neuritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Optic Neuritis

Drugs mentioned

• OCS-05 (OCS-05)

Snippet

Sponsor: Oculis | Conditions: Optic Neuritis | Phase 2 | Status: COMPLETED